When researchers discover a new mechanism of action for Alzheimer’s disease in a Traditional Chinese Medicine drug.
For centuries, TCM has emphasised the strong link between the gut and the brain.
Recent Developments and Outlook for Alzheimer’s Disease Treatments
In a special report published on December 5, 2025, we had concluded that:
"All over, unfortunately, 2025 did not provide anything very promising for the 55 million Alzheimer's patients and their caregivers".
Update on Alzheimer’s disease treatments2025 brings disappointing news for Alzheimer’s patients in
Hommage à Ernest DUCHESNE (1874-1912)
17 décembre 1897- 17 décembre 2025
Pratiquement personne, en France, ne connaît Ernest Duchesne, médecin militaire français, né le 30 mai 1874 à Paris et décédé le 30 avril 1912 à l’hôpital des armées d’Amélie-les-Bains (où un square porte son nom) des suites d’une infection de tuberculose,
Update on Alzheimer’s disease treatments
2025 brings disappointing news for Alzheimer's patients in Europe: regulatory hurdles for new treatments and major clinical trial failures.
Cell and Gene Therapies: A Perspective
Cell and gene therapies promise medical breakthroughs, but manufacturing complexity, $2M price tags, and patient journey challenges force major pharma exits.
Roche and Alzheimer’s disease
SPECIAL REPORT 25.09
Roche and Alzheimer’s disease
On July 28, at the Alzheimer’s Association International Conference (AAIC) held in Toronto (Canada), Roche presented new data from its development portfolio including additional diagnostics outcomes.
In several oral presentations Roche disclosed its latest results from the ongoing trontinemab’s
Sanofi au plus bas depuis trois ans.
SPECIAL REPORT 25.08
Sanofi au plus bas depuis trois ans.
Chers anciens collègues,
Ancien salarié et dirigeant de Sanofi je reste, comme de nombreux d’entre vous, très attentif à son évolution. Le 31 juillet est à nouveau une journée sombre pour le Groupe puisque le cours de son